C3 and endometriosis: It has been found that C3 inhibitors are probably a novel promising candidate used for endometriosis treatment theoretically in two pathways: One, blocking the initial inflammatory signal cascade and, two, relieving the inhibition of C3 on NK cytotoxicity (69).